Education
- MBA, Business Administration, University of Kentucky Gatton College of Business and Economics
- PharmD, Pharmacy Practice, University of Kentucky College of Pharmacy
- PhD, Pharmaceutical Health Services Research, Pharmacoeconomics Track, University of Maryland, Baltimore . Project: Developing a patient-driven cost-effectiveness analysis of pharmacological treatments for patients with chronic hepatitis C
Biography
Dr. Joey Mattingly has been in pharmacy for over twenty years, with pharmacy operations experience as an entry-level technician, staff pharmacist, pharmacy manager, district manager for a major pharmacy chain, and private equity start-up director for a long-term care pharmacy operation serving multiple states. Dr. Mattingly left the private sector in 2014 to pursue an academic career as an Assistant Professor at the University of Maryland School of Pharmacy while simultaneously earning his Doctor of Philosophy in Health Services Research with a specific focus on pharmacoeconomics.
Since 2014, Dr. Mattingly has developed a research portfolio that primarily focuses on drug pricing policy where he has engaged policymakers at local, state, and federal levels, including serving as Speaker of the House of Delegates and Trustee for the American Pharmacists Association (APhA) from 2019-2021. From November 2022 to April 2023, Dr. Mattingly served as an advisor to the Center of Medicare and Medicaid Services (CMS) to aid in the implementation of the new “Drug Price Negotiation Program” authorized by Congress through the Inflation Reduction Act. Most recently, he was named a Research Fellow for the National Association of Insurance Commissioners (NAIC) to help inform policy on pharmacy benefit manager practices.
In addition to drug pricing, Dr. Mattingly has led or co-led multiple federal research proposals aimed at improving patient outcomes through a health equities research lens (U01FD007563 and U01MD017437). Additionally, he led a subaward to a large cooperative agreement with the Food & Drug Administration (U01FD005946) focused on improving diversity in patient engagement activities. This experience with health disparities research was intended to better understand policy implications that may exacerbate disparities in multiple priority populations to ensure our cost-effectiveness methods incorporate health equity impacts.
Dr. Mattingly has previously served as an advisor on Effectiveness and Decision Science for the Patient-Centered Outcomes Research Institute, the Maryland Department of Health Prescription Drug Monitoring Program, and the Maryland Prescription Drug Affordability Stakeholder Council. He also serves as an Editorial Advisory Board member for the American Journal of Pharmaceutical Education and PharmacoEconomics - Open.
Professional Experience
University of Utah College of Pharmacy
- Director, Health Economics & Value Assessment, UHealth Strategy. Jan 2024 – Present
- Vice-Chair of Research, Department of Pharmacotherapy. Nov 2022 – Present
- Associate Professor. Nov 2022 – Present
Centers for Medicare and Medicaid Services
- Special Advisor for Inflation Reduction Act Implementation. Dec 2022 – April 2023
Johns Hopkins University Carey Business School
- Affiliate Scholar, Hopkins Business of Health Initiative. July 2021 – Present
University of Maryland School of Pharmacy
- Vice-Chair of Academic Affairs, Pharmaceutical Health Services Associate Professor. Dec 2019 – Nov 2022
- Associate Professor. July 2019 – Nov 2022
- Director of Operations, The PATIENTS Program. Sep 2016 – Nov 2022
- Assistant Professor, Department of Pharmacy Practice and Science. April 2014 – July 2019
Omnicare, Inc.
- Consultant Pharmacist. Feb 2014 – April 2014
AlixaRx
- Pharmacy Director / General Manager. July 2012 – Sep 2013
The Kroger Company
- Pharmacy District Manager (District 6 – Mid South). Jan 2012 – July 2012
- Pharmacy Manager (Stores L389, L366, L780, L191). Feb 2010 – Jan 2012
- Pharmacist and EPRN Super Trainer (Mid South). March 2009 – Feb 2010
- Pharmacy Technician / Intern. Jan 2004 – March 2009